Big Gain For Quince Therapeutics Inc Com

Fri, Jan 27, 2023 at 07:00 PM

Quince Therapeutics Inc Com (QNCX:NASDAQ) jumped higher at $1.08, a gain of 33.7%. On Fri, Jan 27, 2023, QNCX:NASDAQ hit a New 2-Week High of $1.08. From Fri, Jan 13, 2023, the stock recorded 55.56% Up Days and 40.00% Green Days

The stock spiked on Fri, Jan 27, 2023 at $1.47 with a volume of 63M+.

About Quince Therapeutics Inc Com (QNCX:NASDAQ)

Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases.

Top 10 Gainers:

Schmitt Industries, Inc. (SMIT:NASDAQ), 282%
FOXO Technologies Inc. Class A (FOXO:NYSEMKT), 95.86%
BuzzFeed Inc. (BZFD:NASDAQ), 85.17%
Polished Inc Com (POL:NYSEMKT), 55.7%
Applied UV Inc. (AUVI:NASDAQ), 52.88%
Lucid Group Inc. (LCID:NASDAQ), 43%
VivoPower International PLC (VVPR:NASDAQ), 36.99%
Quince Therapeutics Inc Com (QNCX:NASDAQ), 33.66%
Phoenix Motor Inc. (PEV:NASDAQ), 30.63%
CN Energy Group Inc. (CNEY:NASDAQ), 29.17%